SG Americas Securities’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-27,466
| Closed | -$912K | – | 3668 |
|
|
2022
Q4 | $912K | Sell |
27,466
-15,544
| -36% | -$501K | 0.01% | 1032 |
|
|
2022
Q3 | $1.36M | Buy |
43,010
+21,382
| +99% | +$692K | 0.02% | 814 |
|
|
2022
Q2 | $658K | Sell |
21,628
-41,060
| -65% | -$1.11M | 0.01% | 1708 |
|
|
2022
Q1 | $1.63M | Buy |
62,688
+13,536
| +28% | +$322K | 0.01% | 1063 |
|
|
2021
Q4 | $1M | Sell |
49,152
-4,241
| -8% | -$81.3K | 0.01% | 1643 |
|
|
2021
Q3 | $1.03M | Buy |
+53,393
| New | +$1.06M | ﹤0.01% | 1886 |
|
|
2021
Q2 | – | Sell |
-9,715
| Closed | -$255K | – | 3365 |
|
|
2021
Q1 | $255K | Sell |
9,715
-13,308
| -58% | -$316K | ﹤0.01% | 2507 |
|
|
2020
Q4 | $430K | Buy |
+23,023
| New | +$430K | ﹤0.01% | 2089 |
|
|
2020
Q3 | – | Sell |
-27,733
| Closed | -$646K | – | 3685 |
|
|
2020
Q2 | $646K | Buy |
27,733
+12,821
| +86% | +$186K | 0.01% | 1843 |
|
|
2020
Q1 | $125K | Buy |
14,912
+4,677
| +46% | +$39.4K | ﹤0.01% | 2832 |
|
|
2019
Q4 | $100K | Buy |
+10,235
| New | +$96.1K | ﹤0.01% | 2963 |
|
|
2019
Q2 | – | Sell |
-13,941
| Closed | -$246K | – | 3539 |
|
|
2019
Q1 | $246K | Buy |
+13,941
| New | +$232K | ﹤0.01% | 2424 |
|
|
2018
Q3 | – | Sell |
-11,742
| Closed | -$187K | – | 3543 |
|
|
2018
Q2 | $187K | Buy |
11,742
+4,404
| +60% | +$65.7K | ﹤0.01% | 2641 |
|
|
2018
Q1 | $104K | Buy |
+7,338
| New | +$109K | ﹤0.01% | 2939 |
|
|
2017
Q4 | – | Sell |
-20,351
| Closed | -$291K | – | 3757 |
|
|
2017
Q3 | $291K | Buy |
20,351
+5,210
| +34% | +$74.4K | ﹤0.01% | 2264 |
|
|
2017
Q2 | $238K | Buy |
+15,141
| New | +$218K | ﹤0.01% | 2300 |
|
|
2016
Q4 | – | Sell |
-12,194
| Closed | -$235K | – | 3565 |
|
|
2016
Q3 | $235K | Buy |
+12,194
| New | +$239K | ﹤0.01% | 2353 |
|
|
2015
Q1 | – | Sell |
-8,716
| Closed | -$143K | – | 3173 |
|
|
2014
Q4 | $143K | Buy |
+8,716
| New | +$150K | ﹤0.01% | 2676 |
|
|
2013
Q4 | – | Sell |
-7,347
| Closed | -$174K | – | 3109 |
|
|
2013
Q3 | $174K | Buy |
+7,347
| New | +$172K | ﹤0.01% | 2275 |
|
Other funds holding VIVO
SG Americas Securities's VIVO Position: Q1 2023 in Review
SG Americas Securities sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 27,466 shares — an estimated $912K sold.
SG Americas Securities first reported a position in VIVO in Q3 2013 and held it in 19 quarters. The position peaked at $1.63M in Q1 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- SG Americas Securities reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- SG Americas Securities sold 27,466 Meridian Bioscience Inc shares in Q1 2023, an estimated $912K.
- SG Americas Securities first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 19 quarters.
- SG Americas Securities's Meridian Bioscience Inc position peaked at $1.63M in Q1 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.